We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$216M
AUM Growth
-$36.8M
Cap. Flow
-$46.8M
Cap. Flow %
-21.63%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
2
Avg Time Held Equity + Options
11 quarters
Top 10 Avg Time Held Equity + Options
11 quarters
Top 20 Avg Time Held Equity + Options
11 quarters
Avg Time Held Equity only
11 quarters
Top 10 Avg Time Held Equity only
11 quarters
Top 20 Avg Time Held Equity only
11 quarters

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$46.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BHVN icon
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$168M 77.6%
1,111,111
– –
2018 Q4
15 quarters
BCRX icon
2
BioCryst Pharmaceuticals
BCRX
$2.14B
$48.5M 22.39%
3,846,154
– –
2021 Q4
3 quarters
VIRX icon
3
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$16K 0.01%
3,700
– –
2018 Q4
15 quarters
EPZM
4
CALL
DELISTED
Epizyme, Inc
EPZM
– –
-2,575,450
Closed -$3.79M –
EPZM
5
DELISTED
Epizyme, Inc
EPZM
– –
-31,841,394
Closed -$46.8M –

Similar funds

PC
Paradoxiom Capital Stamford, Connecticut $154M AUM
LA
LPF Advisors Sarasota, Florida $122M AUM 3.12% 1-Year Est. Return
TP
Thunderbird Partners London, United Kingdom $113M AUM 8.51% 1-Year Est. Return
SC
Serenity Capital Palo Alto, California $167M AUM
MADFP
Michael A Dubis Financial Planning Middleton, Wisconsin $103M AUM
RM
RCF Management Denver, Colorado $103M AUM
NC
Napatree Capital Westerly, Rhode Island $178M AUM 8.09% 1-Year Est. Return
GWA
GGM Wealth Advisors Baltimore, Maryland $180M AUM 10.57% 1-Year Est. Return

RP Management's Q3 2022 Portfolio in Review

As of Q3 2022, RP Management held 5 positions worth $216M, down 15% from $253M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RP Management withdrew a net $46.8M in Q3 2022, closing 2 positions. Its most notable exit was Epizyme, Inc, an estimated $46.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

  • RP Management fully exited Epizyme, Inc in Q3 2022, selling an estimated $46.8M.
  • RP Management's ten largest holdings make up 100% of its $216M portfolio in Q3 2022.
  • RP Management opened 0 new positions and closed 2 in Q3 2022.
  • RP Management's portfolio value fell 15% quarter-over-quarter to $216M.

Based on RP Management's 13F filing for Q3 2022, filed 14 Nov 2022.